Difference between revisions of "Fluoxetine-trazodone"
From Psychiatrienet
| Line 3: | Line 3: | ||
| to = trazodone | | to = trazodone | ||
| stop = | | stop = | ||
| − | + | {{stopFluoxetine1}} | |
| − | |||
| start = | | start = | ||
| − | * '''Day | + | * '''Day 2-22:''' A wash-out period is needed. |
| − | * '''Day | + | * '''Day 23:''' Start trazodone in a dosage of 100-150 mg/day. |
| − | * '''After day | + | * '''After day 29:''' If necessary, increase gradually the dosage of trazodone to a maximum of 400 mg/day. |
| info = | | info = | ||
| + | {{longt1/2fluvox}} | ||
* Fluoxetine slows the metabolism of trazodone via CYP2D6, so caution is necessary for at least four weeks. | * Fluoxetine slows the metabolism of trazodone via CYP2D6, so caution is necessary for at least four weeks. | ||
* {{theorSS}} | * {{theorSS}} | ||
}} | }} | ||
Revision as of 15:39, 28 October 2015
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Switch medication from fluoxetine to trazodone.[1] [2]
Stop fluoxetine - Before day 1: reduce dosage of fluoxetine with about 20 mg per week.
- Day 1: when a dosage of 20 mg/day is reached, stop fluoxetine.
Start trazodone- Day 2-22: A wash-out period is needed.
- Day 23: Start trazodone in a dosage of 100-150 mg/day.
- After day 29: If necessary, increase gradually the dosage of trazodone to a maximum of 400 mg/day.
More information- Fluoxetine and its metababolite desmethyl-fluoxetine have a very long elimination time of about 1 week; phasing out fluoxetine is therefore not necessary.
- Fluoxetine slows the metabolism of trazodone via CYP2D6, so caution is necessary for at least four weeks.
- Occurrence of the serotonin syndrome is not likely, but theoretically possible, so caution is necessary.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
